Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar. Serebruany VL, Fortmann SD, Kim MH. Cardiology. 2016;133(2):69-72. doi: 10.1159/000440798. Epub 2015 Oct 22. PMID: 26488178 Clinical Trial.

Activity: Other activity typesOther

Period2015